Pulmonx Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9.1% | -2.2% | +10.2% | -1.9% | +16.6% | -5.2% | +5.9% | -9.9% | +5.1% | -8.9% | +10.5% | – | |
| – | +7.3% | -2.0% | +12.3% | -2.1% | +15.2% | +0.3% | +7.4% | -18.1% | -7.2% | -10.2% | +10.4% | – | |
| – | +9.8% | -2.3% | +9.5% | -1.8% | +17.1% | -7.1% | +5.3% | -6.7% | +9.3% | -8.5% | +10.6% | – | |
| – | -7.7% | +8.1% | +33.4% | -33.3% | +6.9% | +18.9% | +11.6% | -8.7% | -5.4% | +6.9% | +2.8% | – | |
| – | -18.6% | +25.0% | +3.7% | +0.4% | -24.8% | +36.9% | +2.1% | -4.1% | -10.7% | +5.4% | -9.7% | – | |
| – | +0.0% | +1.0% | +8.5% | -5.7% | +6.4% | -0.3% | +3.6% | -4.9% | -9.9% | +5.7% | -7.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.3% | -2.4% | +0.9% | +0.0% | -5.5% | -7.2% | +2.3% | +0.8% | -4.3% | +26.8% | +24.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +320.3% | -25.0% | -54.8% | +128.6% | -80.2% | +255.3% | +31.1% | -27.7% | +45.3% | -19.9% | -10.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.